Gene · 6738
RO60: Ro60, Y RNA binding protein
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. RO60: Ro60, Y RNA binding protein. Genes, record 6738. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6738
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P10155 | RNA-binding protein RO60 | 538 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents36
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 68386 | P10155 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 68390 | P10155 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 68391 | P10155 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 8233 | P10155 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 8401 | P10155 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 8401 | P10155 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 8233 | P10155 | Espacenet |
| EP 4405465 A1 | 2024-07-31 | 7 | P10155 | Espacenet |
| JP 2023552307 A | 2023-12-15 | 23 | P10155 | Espacenet |
| KR 1020230121064 A | 2023-08-17 | 23 | P10155 | Espacenet |
1 to 10 of 36
See all 36 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants810
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | RO60 papers | Newest fiscal year |
|---|---|---|---|
| U54GM104938 | Oklahoma Shared Clinical and Translational Resources | 23 | 2025 |
| ZIACL090034 | Mechanisms of Pain and Immune Processes | 9 | 2025 |
| ZIABC011757 | Biogenesis, Function and Turnover of Noncoding RNAs | 8 | 2025 |
| ZIADE000704 | Clinical and Mechanistic Investigations of Salivary Gland Dysfunction | 8 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 6 | 2025 |
| U19AI110483 | Regulation of B cell Responses in SLE and Other Autoimmune Diseases | 6 | 2025 |
| P30AR073750 | Oklahoma Rheumatic Disease Research Cores Center | 5 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 5 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 4 | 2025 |
| UM1AI144292 | Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail Success | 4 | 2025 |
1 to 10 of 810Source NIH's project files
See all 810 nih grantsPapers1,582
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic loci responsible for atrioventricular block in children. | Front Cell Dev Biol | 2026 | 42798645 | PubTator, text mining | PubMed |
| Distinction Between Anti-Ro52/TRIM21 and Anti-Ro60/TROVE2 in the Ro/SSA Autoantibody System. | J Rheumatol | 2026 | 42744398 | PubTator, text mining | PubMed |
Acute EBV-Associated Systemic Inflammatory Syndrome Presenting as PUO With FDG-Avid Generalized Lymphadenopathy, Autoimmune Serological Positivity and Myopericarditis Mimicking Lymphoma and Connective Tissue Disease: A Diagnostic Challenge. | Cureus | 2026 | 42669013 | PubTator, text mining | PubMed |
| Association of baseline anti-Ro52 seropositivity with connective tissue disease development following interferon-α therapy in patients with chronic hepatitis B. | Clin Rheumatol | 2026 | 42566073 | PubTator, text mining | PubMed |
| Post-Translational Modifications Modulate the HLA-DR3 Restricted Epitope Landscape of Sjögren's Associated Autoantigens. | Medicina (Kaunas) | 2026 | 42356043 | PubTator, text mining | PubMed |
| Multicenter Analytical Comparison of Automated Quantitative Assays Versus Line Immunoassay for Anti-Ro/La Antibody Detection in Primary Sjögren's Syndrome. | J Immunol Res | 2026 | 42322042 | PubTator, text mining | PubMed |
| Systems serology identifies FcR-related autoantibody signatures and functions for Sjögren's syndrome. | EMBO Mol Med | 2026 | 42310390 | PubTator, text mining | PubMed |
| Defective B cell tolerance in SLE lymph nodes underpins VH4-34 "clonal damnation" and PD-1+TOX+ autoreactive B cells expansion. | medRxiv | 2026 | 42238417 | PubTator, text mining | PubMed |
| When help is harm. | Sci Adv | 2026 | 42234762 | PubTator, text mining | PubMed |
| Identification of a shared antigen linking CD4+ T and B cell pathology in Sjögren's disease. | Sci Adv | 2026 | 42234741 | PubTator, text mining | PubMed |
1 to 10 of 1,582
See all 1,582 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6738
GET https://conductscience.org/api/genes/v1/6738/patents?page=2